Use of Virtual CT and On-Treatment MRI to Reduce Radiation Dose and Anesthesia Exposure Associated With the Adaptive Workflow in Pediatric Patients Treated With Intensity Modulated Proton Therapy

Overview

Journal Adv Radiat Oncol

Specialty Oncology

Date 2024 Nov 29

PMID 39610801

Authors

Khadija Sheikh

Ryan Oglesby

William T Hrinivich

Heng Li

Matthew M Ladra

Sahaja Acharya

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this study was to determine whether virtual computed tomography (vCT) derived from daily cone beam computed tomography (CBCT), or on-treatment magnetic resonance imaging (MRI) can replace quality assurance computed tomography (qCT) in our clinical workflow to minimize imaging dose and potentially anesthesia exposure in patients requiring plan adaptation.

Methods And Materials: Pediatric patients (age <24 years) treated from 2020 to 2023 with intensity modulated proton therapy with at least 1 qCT during proton therapy were eligible. For cases that required plan adaptation, the dose was recalculated on vCT and compared with same-day qCT as well as the original planning computed tomography (pCT). Anatomic changes triggering plan adaptation were grouped into categories. Two pediatric radiation oncologists verified whether these changes could be detected using CBCT, qCT, and/or MRI. A new adaptive imaging workflow was proposed to limit imaging dose and anesthesia exposure.

Results: One hundred sixty-eight pediatric patients were treated from 2020 to 2023. Across all patients, there were 517 qCT scans and 61 MRI acquired. The median number of qCT scans per patient was 3 (range, 1-5). The treatment plans for 20 patients (12%) were adapted. In all patients requiring plan adaptation, there was a correlation between dose differences in target coverage and maximum body dose when comparing vCT with pCT and qCT with pCT (n = 20, r = 0.79, < .01, and r = 0.32 = .01, respectively). The most common reason for adaptation was tissue change (eg, inflammation, changes in abdominal gas, or diaphragmatic variability) in the beam path (10/20) and changes in tumor volume (6/20). All cases of weight change, tissue change in beam path, and unreproducible setup could be detected on CBCT. All cases of change in tumor volume within the brain were detected on MRI. Replacing the qCT with the vCT was associated with an estimated median reduction of imaging dose by 50% and anesthesia exposure by 1.5 hours.

Conclusions: vCT derived from daily CBCT only or MRI can safely replace qCT for monitoring dosimetric changes to trigger a new pCT in our clinical workflow. This change would potentially reduce imaging dose and anesthesia exposure.

References

Kurz C, Kamp F, Park Y, Zollner C, Rit S, Hansen D . Investigating deformable image registration and scatter correction for CBCT-based dose calculation in adaptive IMPT. Med Phys. 2016; 43(10):5635. DOI: 10.1118/1.4962933. View

Moller D, Khalil A, Knap M, Hoffmann L . Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis. Radiother Oncol. 2013; 110(3):517-22. DOI: 10.1016/j.radonc.2013.10.013. View

Weistrand O, Svensson S . The ANACONDA algorithm for deformable image registration in radiotherapy. Med Phys. 2015; 42(1):40-53. DOI: 10.1118/1.4894702. View

Trnkova P, Zhang Y, Toshito T, Heijmen B, Richter C, Aznar M . A survey of practice patterns for adaptive particle therapy for interfractional changes. Phys Imaging Radiat Oncol. 2023; 26:100442. PMC: 10183663. DOI: 10.1016/j.phro.2023.100442. View

Bischoff M, Ahmad Khalil D, Frisch S, Backer C, Peters S, Friedrich C . Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg. Int J Radiat Oncol Biol Phys. 2024; 120(1):137-148. DOI: 10.1016/j.ijrobp.2024.03.015. View

Kurz C, Dedes G, Resch A, Reiner M, Ganswindt U, Nijhuis R . Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer. Acta Oncol. 2015; 54(9):1651-7. DOI: 10.3109/0284186X.2015.1061206. View

Britton K, Starkschall G, Liu H, Chang J, Bilton S, Ezhil M . Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008; 73(1):94-102. DOI: 10.1016/j.ijrobp.2008.04.016. View

Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R . Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys. 2008; 72(5):1385-95. PMC: 3401022. DOI: 10.1016/j.ijrobp.2008.03.007. View

Baumer C, Frakulli R, Kohl J, Nagaraja S, Steinmeier T, Worawongsakul R . Adaptive Proton Therapy of Pediatric Head and Neck Cases Using MRI-Based Synthetic CTs: Initial Experience of the Prospective KiAPT Study. Cancers (Basel). 2022; 14(11). PMC: 9179385. DOI: 10.3390/cancers14112616. View

10.

Yan D, Vicini F, Wong J, Martinez A . Adaptive radiation therapy. Phys Med Biol. 1997; 42(1):123-32. DOI: 10.1088/0031-9155/42/1/008. View

11.

Jacola L, Anghelescu D, Hall L, Russell K, Zhang H, Wang F . Anesthesia Exposure during Therapy Predicts Neurocognitive Outcomes in Survivors of Childhood Medulloblastoma. J Pediatr. 2020; 223:141-147.e4. PMC: 7387137. DOI: 10.1016/j.jpeds.2020.04.039. View

12.

Kadoya N, Nakajima Y, Saito M, Miyabe Y, Kurooka M, Kito S . Multi-institutional Validation Study of Commercially Available Deformable Image Registration Software for Thoracic Images. Int J Radiat Oncol Biol Phys. 2016; 96(2):422-431. DOI: 10.1016/j.ijrobp.2016.05.012. View

13.

Uh J, Wang C, Acharya S, Krasin M, Hua C . Training a deep neural network coping with diversities in abdominal and pelvic images of children and young adults for CBCT-based adaptive proton therapy. Radiother Oncol. 2021; 160:250-258. DOI: 10.1016/j.radonc.2021.05.006. View

14.

Ladra M, Edgington S, Mahajan A, Grosshans D, Szymonifka J, Khan F . A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol. 2014; 113(1):77-83. PMC: 4298831. DOI: 10.1016/j.radonc.2014.08.033. View

15.

Tsai P, Tseng Y, Shen B, Ackerman C, Zhai H, Yu F . The Applications and Pitfalls of Cone-Beam Computed Tomography-Based Synthetic Computed Tomography for Adaptive Evaluation in Pencil-Beam Scanning Proton Therapy. Cancers (Basel). 2023; 15(20). PMC: 10605451. DOI: 10.3390/cancers15205101. View

16.

van de Schoot A, de Boer P, Crama K, Visser J, Stalpers L, Rasch C . Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer. Acta Oncol. 2016; 55(7):892-9. DOI: 10.3109/0284186X.2016.1139179. View

17.

Acharya S, Wang C, Quesada S, Gargone M, Ates O, Uh J . Adaptive Proton Therapy for Pediatric Patients: Improving the Quality of the Delivered Plan With On-Treatment MRI. Int J Radiat Oncol Biol Phys. 2020; 109(1):242-251. DOI: 10.1016/j.ijrobp.2020.08.036. View

18.

Uh J, Jordan J, Pappo A, Krasin M, Hua C . Adaptive Proton Therapy for Pediatric Parameningeal Rhabdomyosarcoma: On-Treatment Anatomic Changes and Timing to Replanning. Clin Oncol (R Coll Radiol). 2023; 35(4):245-254. PMC: 10783810. DOI: 10.1016/j.clon.2023.01.013. View

19.

Koay E, Lege D, Mohan R, Komaki R, Cox J, Chang J . Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012; 84(5):1093-100. PMC: 3409930. DOI: 10.1016/j.ijrobp.2012.02.041. View

20.

Baliga S, Patel S, El Naqa I, Li X, Cohen L, Howell R . Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2023; 119(2):610-624. DOI: 10.1016/j.ijrobp.2023.08.010. View